Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0027 | 0.7166 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0011 | 0.0756 | 0.0611 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.002 | 0.451 | 0.451 |
Echinococcus multilocularis | musashi | 0.002 | 0.451 | 0.4424 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0027 | 0.7154 | 0.6922 |
Schistosoma mansoni | lamin | 0.002 | 0.451 | 0.4061 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0034 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.3601 | 0.3078 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0029 | 0.7966 | 0.78 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0011 | 0.0756 | 0.0164 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0027 | 0.7166 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0027 | 0.7154 | 0.6922 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0016 | 0.2669 | 0.207 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.359 | 0.3066 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.002 | 0.4402 | 0.3945 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0034 | 1 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.002 | 0.451 | 0.4424 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0154 | 0.0154 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0025 | 0.6436 | 0.5 |
Schistosoma mansoni | lamin | 0.002 | 0.451 | 0.4061 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0034 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 1 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0034 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 1 | 1 |
Giardia lamblia | GTOR | 0.0034 | 1 | 0.5 |
Onchocerca volvulus | 0.002 | 0.451 | 0.5 | |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0027 | 0.7154 | 0.6922 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0027 | 0.7154 | 0.6922 |
Echinococcus granulosus | lamin dm0 | 0.002 | 0.451 | 0.4424 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.5421 | 0.5047 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0034 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.002 | 0.432 | 0.3855 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.002 | 0.4402 | 0.3945 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.451 | 0.451 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.3601 | 0.3078 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.3601 | 0.3078 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0034 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0011 | 0.0601 | 0.0601 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0027 | 0.7166 | 0.6934 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0011 | 0.0756 | 0.0756 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.002 | 0.451 | 0.4159 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.512 | 0.4722 |
Echinococcus granulosus | lamin | 0.002 | 0.451 | 0.4424 |
Brugia malayi | intermediate filament protein | 0.002 | 0.451 | 0.4159 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0027 | 0.7154 | 0.6922 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.359 | 0.3066 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.3601 | 0.3078 |
Loa Loa (eye worm) | intermediate filament protein | 0.002 | 0.451 | 0.451 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.4356 | 0.4356 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0034 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.6436 | 0.6145 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0034 | 1 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0034 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0034 | 1 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0011 | 0.0756 | 0.0611 |
Echinococcus multilocularis | lamin dm0 | 0.002 | 0.451 | 0.4424 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0018 | 0.359 | 0.3066 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.002 | 0.4402 | 0.3945 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0034 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.002 | 0.432 | 0.3855 |
Onchocerca volvulus | 0.002 | 0.451 | 0.5 | |
Echinococcus multilocularis | lamin | 0.002 | 0.451 | 0.4424 |
Schistosoma mansoni | intermediate filament proteins | 0.002 | 0.451 | 0.4061 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0014 | 0.1868 | 0.1204 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0034 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.